Aurora to Host a Retail Investor Town Hall on August 20, 2026
Get Alerts AUR Hot Sheet
Join SI Premium – FREE
PITTSBURGH--(BUSINESS WIRE)-- Aurora Innovation, Inc. (NASDAQ: AUR) today announced it will host a virtual Retail Investor Town Hall with Co-founder and CEO Chris Urmson and CFO David Maday on August 20, 2026 from 12:00 p.m. - 12:30 p.m. Eastern time. The event will be livestreamed at Aurora Retail Investor Town Hall.
Investors are invited to submit questions for management prior to the livestream via the submission page. Question submissions and upvoting will be available until August 20, 2026 at 11:00 a.m. Eastern time.
A replay will be available for 30 days following the event.
Investors can email [email protected] for any support inquiries.
About Aurora
Aurora (Nasdaq: AUR) is delivering the benefits of self-driving technology safely, quickly, and broadly to make transportation safer, increasingly accessible, and more reliable and efficient than ever before. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles, and underpins Aurora’s driver as a service product for trucking. Aurora is working with industry leaders across the transportation ecosystem, including AUMOVIO, FedEx, Hirschbach, McLane, NVIDIA, PACCAR, Ryder, Schneider, Toyota, Uber, Uber Freight, Volvo Trucks, Volvo Autonomous Solutions, and Werner. To learn more, visit aurora.tech.
Aurora Overview
Aurora Press Kit
View source version on businesswire.com: https://www.businesswire.com/news/home/20260806600557/en/
Investor Relations:
Stacy Feit
[email protected]
Media:
[email protected]
Source: Aurora Innovation, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Infrrd Launches IDPForge, a Self-Serve Document Automation API for Developers
- Yumeya Furniture Redefines Commercial Dining with Professional Restaurant Furniture Solutions
- U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share